Castleman disease: clinical features, pathology, and treatment outcomes in 12 cases - Top-Institutions - MDSpire

Castleman disease: clinical features, pathology, and treatment outcomes in 12 cases

  • By

  • Yi Gong

  • Huiyang Liu

  • Yuanlong Li

  • Xin Wang

  • Jie Yuan

  • Jianming Wang

  • July 16, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Hematology

  • #2

    Linyi People’s Hospital
    Linyi People’s Hospital

    Linyi, Shandong

    Key Differentiators

    • Hematology

  • #3

    Peking Union Medical College Hospital
    Peking Union Medical College Hospital

    Beijing, Beijing

    Key Differentiators

    • Hematology

Original Source(s)

Castleman disease: clinical features, pathology, and treatment outcomes in 12 cases

  • by Yi Gong, Huiyang Liu, Yuanlong Li, Xin Wang, Jie Yuan, Jianming Wang

  • July 16, 2026

Related Content

GLA is associated with ESCC progression and chemotherapy response via DNA damage repair–related pathways

Updated Asian consensus guidelines for the diagnosis and management of gastrointestinal stromal tumor (2025)

Association of APOBEC mutagenesis with stromal and endothelial niche remodeling and PCDH9-linked signaling alterations in colorectal cancer